Kyle Rose
Stock Analyst at Canaccord Genuity
(2.66)
# 2,184
Out of 5,050 analysts
114
Total ratings
53.26%
Success rate
13.7%
Average return
Main Sectors:
Stocks Rated by Kyle Rose
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SNN Smith & Nephew | Maintains: Hold | $27 | $33.23 | -18.75% | 6 | Feb 26, 2025 | |
| PODD Insulet | Maintains: Buy | $304 → $324 | $319.82 | +1.31% | 16 | Feb 21, 2025 | |
| SYK Stryker | Maintains: Buy | $420 → $435 | $356.03 | +22.18% | 20 | Jan 29, 2025 | |
| GMED Globus Medical | Maintains: Buy | $67 → $71 | $83.89 | -15.37% | 7 | Dec 20, 2023 | |
| ENOV Enovis | Maintains: Buy | $65 → $71 | $28.06 | +153.03% | 3 | Dec 20, 2023 | |
| INMD InMode | Downgrades: Hold | $55 → $22 | $14.45 | +52.25% | 10 | Oct 13, 2023 | |
| SKIN The Beauty Health Company | Assumes: Buy | $10 | $1.40 | +614.29% | 4 | Aug 25, 2023 | |
| ATEC Alphatec Holdings | Maintains: Buy | $17 → $22 | $19.80 | +11.11% | 4 | Aug 4, 2023 | |
| DXCM DexCom | Maintains: Buy | $135 → $150 | $55.00 | +172.73% | 17 | Jul 28, 2023 | |
| RBOT Vicarious Surgical | Maintains: Buy | $360 → $270 | $4.37 | +6,078.49% | 3 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $27 | $15.77 | +71.21% | 3 | May 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $1.17 | +1,182.05% | 1 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $23.57 | -36.36% | 6 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $125 → $122 | $149.00 | -18.12% | 1 | Mar 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $3 → $4 | $3.90 | +2.56% | 4 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $7.45 | - | 2 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $165 → $125 | $88.50 | +41.24% | 7 | Feb 8, 2022 |
Smith & Nephew
Feb 26, 2025
Maintains: Hold
Price Target: $27
Current: $33.23
Upside: -18.75%
Insulet
Feb 21, 2025
Maintains: Buy
Price Target: $304 → $324
Current: $319.82
Upside: +1.31%
Stryker
Jan 29, 2025
Maintains: Buy
Price Target: $420 → $435
Current: $356.03
Upside: +22.18%
Globus Medical
Dec 20, 2023
Maintains: Buy
Price Target: $67 → $71
Current: $83.89
Upside: -15.37%
Enovis
Dec 20, 2023
Maintains: Buy
Price Target: $65 → $71
Current: $28.06
Upside: +153.03%
InMode
Oct 13, 2023
Downgrades: Hold
Price Target: $55 → $22
Current: $14.45
Upside: +52.25%
The Beauty Health Company
Aug 25, 2023
Assumes: Buy
Price Target: $10
Current: $1.40
Upside: +614.29%
Alphatec Holdings
Aug 4, 2023
Maintains: Buy
Price Target: $17 → $22
Current: $19.80
Upside: +11.11%
DexCom
Jul 28, 2023
Maintains: Buy
Price Target: $135 → $150
Current: $55.00
Upside: +172.73%
Vicarious Surgical
May 31, 2023
Maintains: Buy
Price Target: $360 → $270
Current: $4.37
Upside: +6,078.49%
May 2, 2023
Maintains: Buy
Price Target: $24 → $27
Current: $15.77
Upside: +71.21%
Mar 28, 2023
Reiterates: Buy
Price Target: $15
Current: $1.17
Upside: +1,182.05%
Mar 28, 2023
Reiterates: Buy
Price Target: $15
Current: $23.57
Upside: -36.36%
Mar 1, 2023
Maintains: Market Perform
Price Target: $125 → $122
Current: $149.00
Upside: -18.12%
Nov 10, 2022
Upgrades: Buy
Price Target: $3 → $4
Current: $3.90
Upside: +2.56%
Nov 9, 2022
Downgrades: Hold
Price Target: n/a
Current: $7.45
Upside: -
Feb 8, 2022
Downgrades: Hold
Price Target: $165 → $125
Current: $88.50
Upside: +41.24%